#ACMT2025
Important Dates

 Accepting Abstracts
September 1 – November 15, 2024

MTF Shark Tank Deadline
December 4, 2024

MedTox Case Panel Deadline
January 10, 2025

Open Mic Competition Deadline
January 10, 2025

Early-Bird Registration Deadline
February 21, 2025

ACMT Symposium: Harm Reduction in the Management of Substance Use Disorders (SUD)

Join the American College of Medical Toxicology (ACMT) on Thursday, April 3, 2025 for the ACMT Symposium: Harm Reduction in the Management of SUD at the Fairmont Hotel in Vancouver, Canada.

Harm reduction has become a key tool in managing substance use disorders (SUD), yet remains loosely defined. It encompasses various measures, including needle exchanges, naloxone distribution, safe consumption sites, and fentanyl test strips. While needle exchange programs have proven effective in reducing infections from intravenous drug use, the impact of other harm reduction strategies is harder to quantify.

Support for harm reduction varies among professionals and the recovery community, with its success depending on when and where the tools are used, the methods chosen, and the combination with other treatments. Different settings—emergency departments, ICUs, or outpatient clinics—may require distinct approaches.

Vancouver’s pioneering leadership in harm reduction makes it an ideal location for this full-day in-person symposium, which will explore harm reduction in detail, presenting the latest evidence and examining its application in special populations, healthcare settings, and recovery stages. Topics include integrating harm reduction with SUD medications and substance use education, inpatient high-dose methadone titration, and a case-based panel discussion on “Lived Experience.” The symposium will appeal to a wide range of professionals in medicine, including those in family medicine, emergency medicine, medical toxicology, addiction medicine, and beyond.

Learning Objectives:

1. Analyze the evidence surrounding various harm reduction strategies in the management of substance use disorders, with a focus on their effectiveness across different settings and populations.
2. Evaluate the role of harm reduction tools at different stages of the recovery process and identify how they can be integrated with other treatment modalities to optimize patient outcomes.
3. Discuss the ethical and practical considerations of harm reduction practices, including the perspectives of healthcare providers, patients, and the broader recovery community.

Continuing Education: Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity. It is expected that learners will receive up to 6.00 credits for learning and change.